BTR Capital Management’s Celgene Corp CELG Stock Holding History

BTR Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,065	Closed	-$216K	–	152
2017 Q4	$216K	Hold	2,065	–	–	0.04%	141
2017 Q3	$301K	Sell	2,065 -900	-30%	-$123K	0.06%	118
2017 Q2	$385K	Sell	2,965 -600	-17%	-$73.5K	0.08%	112
2017 Q1	$444K	Buy	+3,565	New	+$427K	0.09%	107
2016 Q1	–	Sell	-2,000	Closed	-$240K	–	170
2015 Q4	$240K	Buy	+2,000	New	+$231K	0.05%	152
2015 Q3	–	Sell	-1,750	Closed	-$203K	–	178
2015 Q2	$203K	Buy	+1,750	New	+$200K	0.05%	149

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BTR Capital Management's CELG Position: Q1 2018 in Review

BTR Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,065 shares — an estimated $216K sold.

BTR Capital Management first reported a position in CELG in Q2 2015 and held it in 6 quarters. The position peaked at $444K in Q1 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

BTR Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
BTR Capital Management sold 2,065 Celgene Corp shares in Q1 2018, an estimated $216K.
BTR Capital Management first reported a position in Celgene Corp in Q2 2015 and held it in 6 quarters.
BTR Capital Management's Celgene Corp position peaked at $444K in Q1 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on BTR Capital Management's 13F filing for Q1 2018, filed 1 May 2018.